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Abstract: D-DIBOA (4-hydroxy-(2H)-1,4-benzoxazin-3-(4H)-one) is an allelopathic-derived
compound with interesting herbicidal, fungicidal, and insecticide properties whose production
has been successfully achieved by biocatalysis using a genetically engineered Escherichia coli strain.
However, improvement and scaling-up of this process are hampered by the current methodology
for D-DIBOA quantification, which is based on high-performance liquid chromatographic (HPLC),
a time-consuming technique that requires expensive equipment and the use of environmentally unsafe
solvents. In this work, we established and validated a rapid, simple, and sensitive spectrophotometric
method for the quantification of the D-DIBOA produced by whole-cell biocatalysis, with limits
of detection and quantification of 0.0165 and 0.0501 µmol·mL−1 respectively. This analysis takes
place in only a few seconds and can be carried out using 100 µL of the sample in a microtiter plate
reader. We performed several whole-cell biocatalysis strategies to optimize the process by monitoring
D-DIBOA production every hour to keep control of both precursor and D-DIBOA concentrations in
the bioreactor. These experiments allowed increasing the D-DIBOA production from the previously
reported 5.01 mM up to 7.17 mM (43% increase). This methodology will facilitate processes such as
the optimization of the biocatalyst, the scaling up, and the downstream purification.
Keywords: whole-cell biocatalysis; D-DIBOA; spectrophotometric method; nitroreductase NfsB
1. Introduction
The use of allelochemicals from plants in agriculture is one of the most attractive strategies
to avoid the negative impacts that weeds have on crops without harming the environment [1,2].
Benzohydroxamic acids are a group of these natural allelochemicals present in cereals such as wheat, rye,
and maize [3]. These compounds are well known for their interesting biological properties as herbicides,
fungicides, and insecticides [4]. Among them, DIBOA (2,4-dihydroxy-(2H)-1,4-benzoxazin-3-(4H)one)
(Figure 1a) is considered an attractive model of natural herbicide [5] that shows high biodegradability
in soils, and therefore, has a low environmental impact [6]. However, the main drawback of the use
of DIBOA and other allelopathic compounds in agriculture is their reduced natural production [7].
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An alternative is a chemical synthesis, a process that usually reaches relatively high yields [2]. In the
case of DIBOA, the synthesis of the active analogous D-DIBOA (2-deoxy-DIBOA) is possible in a
two-step sequence (Figure 1b) [2]. However, the scaling-up of this synthesis is hindered by the second
step, which uses an expensive catalyst and is an exothermic reaction, with hydrogen release and a
moderate molar yield (70%).
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possible to carry out many assays at bioreactor scale and to achieve the automation of the process to 
obtain profitable yields and productivities. 
Spectrophotometric methods are often used to quantify biological molecules because they allow 
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Figure 1. (a) DIBOA and D-DIBOA molecular structures and (b) D-DIBOA synthesis which involves
two steps: The first step is a chemical reaction that using 2-nitrophenol starting material and ethyl
bromoacetate to produce ethyl-2-(2′-nitrophenoxi)acetate (the precursor in the second step) by a
nucleophilic substitution. The second step involves the reduction of a nitro group followed by a
cyclization that is catalyzed by the nitroreductase (NfsB) enzyme (dashed box). This second reaction is
catalyzed by NfsB nitroreductase which is NAD(P)H-dependent (*).
Nevertheless, the use of an engineered Escherichia coli strain overexpressing the autologous
nitroreductase enzyme NfsB as a whole-cell biocatalyst can get over the drawbacks of the second
step of this chemical synthesis [8]. Indeed, the engineered E. coli strain was capable of catalyzing the
conversion of the precursor to D-DIBOA and exporting it out to the culture medium with a molar yield
similar to that of the chemical synthesis. Furthermore, the optimization of the mutant background
(∆lapA∆fliQ/pBAD-NfsB strain), the use of an adjusted defined medium, and the addition of precursor
in several loads made it possible to produce up to 5.01 mM D-DIBOA or 100% molar yield at lower
concentration (4.4 mM) [9]. All these improvements carried out at laboratory scale encouraged us
to tackle the optimization and the scaling-up of the biotechnological production of this biological
herbicide. Nevertheless, one of the main bottlenecks to achieve these goals is the methodology
for D-DIBOA quantification, which is currently based on high-performance liquid chromatography
(HPLC). Although this technique is very accurate, it has several isadvantages when the measurement
of a high numb of samples o a rapid a alysis s needed. HPLC requires expe sive op ration and
instrumentation, and time-consuming sample rocessing. Besides, it also requires experience in the
handling of the equipme t [10].
Ind ed, thi is concerni g drawback since the optimization and scalin -up of a bio rocess require
intense experimental work going from laboratory scale through the pilot plant to the industrial
implementation of the production. Therefore, it is essential to set up a fast and efficient analytical
method to monitor D-DIBOA production in close to real-time, which would make it possible to carry
out many assays at bioreactor scale and to achieve the automation of the process to obtain profitable
yields and productivities.
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Spectrophotometric methods are often used to quantify biological molecules because they
allow quick and reliable ways to measure multiple biological samples. For this reason, classical
methods for protein [11,12] or sugar [13] quantification are still routinely used, even though
more accurate methodologies, such as mass spectrometry, have been tuned up in the last
decades [14]. New spectrophotometric methods are still currently developed for fast detection of,
for instance, environmentally toxic/hazardous substances such as pharmaceutical pollutants [15].
Particularly appealing is the application of this methodology for the quantification of compounds
produced through biotransformation processes, since they allow the monitoring of the procedure,
which helps to optimize the production [16].
Ferric chloride (FeCl3) has been previously used for organic compound determination because
hydroxamic acids typically coordinate iron (III) with high affinity in acidic-alcoholic FeCl3 solutions
and generate blue colored complexes [17], which allows their detection [18–20]. Nonetheless, in these
studies, the acidic-alcoholic FeCl3 solution was applied to plant or soil natural extracts containing a mix
of several hydroxamic acids, all of which contributed to the development of colored complexes with
Fe (III). For this reason, this technique was replaced by more selective and sensitive methodologies
such as gas chromatography (GC) coupled to mass spectrometry (MS) and liquid chromatography
(LC) coupled to ultraviolet (UV) detection, or the even more sensitive LC coupled to MS and tandem
MS. These techniques played essential roles in the detection, separation, and quantification of natural
benzohydroxamic acids isolated from plant tissues or their degradation products in the soil [21].
Nevertheless, in the case of the whole-cell biocatalysis the sample contains a single benzohydroxamic
acid (D-DIBOA). We hypothesized that a complexation reaction of D-DIBOA with Fe (III) in an acidic
medium would generate a blue-colored Fe (III) hydroxamate complex that could be useful for the
quantification of our target product (Figure 2). It is worth noting that the precursor for D-DIBOA
synthesis does not contain the hydroxylamine moiety and would presumably not react with Fe (III)
(Figure 1).
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The methods previously described for the detection of natural benzohydroxamic acids (DIBOA,
DIMBOA) could not be applied directly because they used ethyl acetate extracts from plants or soil and
an acidic-alcoholic FeCl3 solution to generate the colored complexes [18]. However, in the whole-cell
biocatalysis, D-DIBOA, which had not been previously tested for this reaction, is dissolved in an
aqueous solution (the bacterial culture medium). Besides, this alternative method should be as reliable
as HPLC for the quantification of this compound, and also has to be sensitive enough to quantify
D-DIBOA, at least, in the range of millimolar concentration.
To explore the feasibility of this approach, the maximum wavelength absorbances, concentrations,
and compositions of reagents were established in order to carry out the reaction in an efficient and
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economical manner. The possibility of using low volumes was also explored with the aim of quantifying
multiple samples in a microtiter reader plate. Finally, the method was validated by calculating different
parameters such as linearity, accuracy, precision, and sensitivity, in addition to the limit of detection
(LOD) and the limit of quantification (LOQ). Validation was carried out in accordance with the
International Conference on Harmonization (ICH) rules Q2 (R1) [22].
The applicability and utility of the methodology was also tested on real biotransformation
assays. To this end, we performed several biocatalytic strategies by monitoring D-DIBOA using the
∆lapA∆fliQ/pBAD-NfsB strain [9].
2. Results
2.1. Development of a Spectrophotometric Method for D-DIBOA Quantification
2.1.1. Assessment of Maximum Wavelength (λmax) Range for Absorbance of the Fe
(III)-(D-DIBOA)3 Complex
To assess the λmax absorbance of the complex Fe (III)-(D-DIBOA)3, 2 mM D-DIBOA was used to
scan the visible range (OD450–750) with different solvents for D-DIBOA and FeCl3. We first tested a
method previously described to detect hydroxamic acids [18], in which the samples were dissolved in
ethanol and the FeCl3 (0.37 M) solution was prepared in acidic ethanol. Nevertheless, this method
cannot be directly applied to D-DIBOA biocatalysis because the target molecule is dissolved in an
aqueous solution. For this reason, we also assayed the same FeCl3 concentration in acidic water
(pH < 1) for testing D-DIBOA dissolved in M9 culture medium (the same matrix in which D-DIBOA
is produced). The combination of D-DIBOA in M9 and FeCl3 in ethanol was discarded to avoid salt
precipitation. The range of λmax measured in both conditions was 550–600 nm, although the ethanol
dissolved solution also gave irregular results at wavelengths below 500 nm (Figure 3a).
2.1.2. Specificity
Specificity is a key issue for quantification. In our case, this parameter was evaluated by comparing
the scanning spectra of a D-DIBOA solution with and without the two organic compounds from the
biocatalysis that may also be present in the culture media, that is, 2-nitrophenol (as the unreacted
starting material of the first step of the chemical synthesis) and the precursor of D-DIBOA synthesis.
As can be observed in Figure 3b, both 2-nitrophenol and the precursor showed absorbance in the entire
visible spectrum when the acidic-ethanol FeCl3 solution was applied, interfering with the recovery of
D-DIBOA. These interferences were negligible when the acidic water-FeCl3 solution was used, mainly
from O.D. 560 on (Figure 3c). This reactant has the additional advantage of avoiding the use of ethanol,
an expensive organic solvent. An acidic water-FeCl3 solution and a wavelength range of 560–600 nm
were therefore selected for further implementation of the method.
2.1.3. Optimization of the Calibration Curve
A spectrophotometric quantification method requires reliable linearity in the calibration curve in
the range of concentrations to be measured. To investigate whether the absorbance of Fe(III)-(D-DIBOA)3
complex could be used toward this aim, we tested several FeCl3 solutions (0.37, 0.3, 0.2, and 0.1 M;
pH < 1) to optimize the conditions for the maximum absorbance and linearity. We first scanned
the visible spectrum with the four FeCl3 concentrations and a D-DIBOA 2 mM solution, and we
found out that applying 0.1 M FeCl3 did not give differences in OD450–750, probably because the
reactant concentration was too low. On the other hand, 0.37 and 0.3 M showed similar intensities
Figure S1). We therefore selected 0.3 and 0.2 M FeCl3 to establish a calibration curve, using five standard
solutions containing D-DIBOA from 0.375 to 4.500 mM dissolved in M9 medium and analyzed the
linearity of the standard curves by calculating the correlation coefficient (R2) between intensity and
concentrations (Figure 3d). Although the applications of both 0.3 and 0.2 M FeCl3 showed absorbance
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readings in the range of the D-DIBOA solutions tested, the use of 0.2 M FeCl3 gave the best correlation
(R2 = 0.9987). The slope (0.2157) indicates a high degree of sensitivity, sensitivity being the capacity
of the method to distinguish, with a determined degree of reliability, two proximal concentrations
(Figure 3d). Additionally, the 0.2 M FeCl3 solution was more stable than the 0.3 M one, since we
observed some precipitated FeCl3 24 h after the preparation of the latter solution (data not shown).
In these experiments, the volume of the reaction was scaled down to 0.2 mL using a microtiter reader
plate at OD570. This latest optimization reduced the amount of reagent and sample required in the
quantification, which is relevant for whole-cell biocatalysis assays at bench scale (100 mL). Additionally,
it allows the quantification of hundreds of samples in a short time.
In summary, we have been able to establish an economical, low time consuming, and sensitive
method for the quantification of biotechnologically produced D-DIBOA by using 100µL FeCl3 dissolved
in acidic water (0.2 M, pH < 1) and 100 µL of a D-DIBOA sample dissolved in M9 medium, and directly
measured at the wavelength of 570 nm in a microtiter reader plate.
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Figure 3. Spectral absorbance determination of Fe (III)-(D-DIBOA)3 complex, specificity,
and optimization of calibration curves. (a) Spectral absorbance of Fe(III)-(D-DIBOA)3 complex
in ethanol and M9 medium; (b) spectral absorbance curves of: D-DIBOA (DD), precursor (PC),
2-nitrophenol (NP) dissolved in ethanol (Et), in the presence of FeCl3 also dissolved in Et; (c) spectral
absorbance curves of: D-DIBOA, precursor, 2-nitrophenol dissolved in M9, in the presence of FeCl3
dissolved in water; (d) calibration curves of D-DIBOA (mM) by adding FeCl3 0.2 and 0.3 M with pH < 1
and measured spectro t etrically at a wavelength of 570 nm in a microplate reader.
2.1.4. Method Validation
The validation of the sp ctrophotometric analytical t as carried out on the basis of the
following parameters:
Sensitivity: The limit of detection (LOD) and limit of quantification (LOQ) values were 0.0165 and
0.0501 mM, respectively; both being values below the lowest concentration of the linear range (Table 1).
The results indicated that the method is sensitive even at low concentrations (in the range of 50 µM
D-DIBOA concentrations).
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Table 1. Analytical parameters for the complex Fe(III)-(D-DIBOA)3.
Parameter Range
λmax 570 nm








Accuracy: The accuracy of the method was determined by recovery test of known quantities of
D-DIBOA. The values obtained were in the range of 98.24–102.22%, which are into the acceptable range
since the values showed standard deviations less than 2.5% (Tables 1 and 2).






Mean ± SD a (mM)
Mean Recovery (%) ± SD a
(mM)
0.75 0.7368 ± 0.0090 98.24 ± 1.20
1.5 1.5451 ± 0.0149 101.67 ± 1.00
3 3.0667 ± 0.0645 102.22 ± 2.15
a Indicates the mean and standard deviation (SD) of nine replicates (n = 9).
Precision: Inter-analyst analysis showed the higher relative standard deviations (RSD), with
values from 2.4372 to 4.2308% for the highest and the intermediate concentrations. The rest of the
values ranged from 0.9505 up to 2.2833% for method data in the cases of inter-day and intra-day.
In addition, since the Horrat parameter is less than 2 in all the cases, it can be assumed that the method
has satisfactory reproducibility values (Table 3) [23].
Table 3. Precision of proposed analytical method. Concentration found and recovery percentage of








0.75 0.7368 ± 0.0090 1.1476 0.2345
1.5 1.5251 ± 0.0149 0.9505 0.2117
3 3.0667 ± 0.0645 2.0697 0.4998
Inter-day
Same analyst, day 1 and day 2
0.75 0.7347 ± 0.0141 2.2833 0.4666
1.5 1.5270 ± 0.0204 1.1055 0.2463
3 3.0412 ± 0.0532 1.8961 0.4579
Intra-day
Same analyst, day 1, different test
0.75 0.7373 ± 0.0111 2.1773 0.4449
1.5 1.5283 ± 0.0224 1.1790 0.2626
3 3.0698 ± 0.0456 1.7387 0.4198
Inter-analyst
Analyst 1 and 2, day 1
0.75 0.7646 ± 0.0180 3.2860 0.6715
1.5 1.5973 ± 0.0818 4.2308 0.9424
3 3.0908 ± 0.0886 2.4372 0.5885
a Indicates the mean and standard deviation (SD) of nine determinations (n = 9).
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Reagent stability: The FeCl3 solution stability was evaluated for 4 days, by comparing D-DIBOA
quantification prepared on day 1 with a fresh prepared solution. No statistically significant differences
were found between the sets of experiments (data not shown).
2.1.5. Method Reliability
In order to further validate the spectrophotometric method, the correlation between this analysis
and the HPLC one was studied by comparing the recovery percentage in both cases using samples
from different standards, conditions, and experiments. The adjustment between both methodologies
was carried out through regression coefficient calculation (R2), obtaining a value of 0.9994 (Figure 4).
These results show that, in the assayed conditions, the spectrophotometric method is as reliable as the
HPLC one and it can therefore be used to measure D-DIBOA concentration at close to real-time range.
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2.2. Optimization of the Whole-Cell Biocatalysis for D-DIBOA Using the Spectrophotometric
Quantification Method
The applicability of the spectrophotometric method was analyzed by monitoring D-DIBOA
concentration in 100 mL biocatalysis assays carried out at bench scale started with the addition of
an initial precursor load to reach 2.2 mM in the culture medium, as described in the method section.
The aim of these experiments was to monitor D-DIBOA concentration at real time, by applying the
method proposed in this work every hour from 2 to 12 h and at 24 h as final time point. This also
allowed us to stoichiometrically calculate the presence of unreacted precursor. This is a key element to
optimize D-DIBOA production, since precursor concentrations above 2.2 mM inhibited the bacterial
biocatalyst [9].
This series of biotransformation assays was designed as a proof of concept for the application to
the scaling up of D-DIBOA production by monitoring not only D-DIBOA and precursor concentrations
(left panels in Figure 5), but also other fundamental parameters, such as bacterial growth and glucose
consumption (right panels in Figure 5) and NH4+ consumption. Thus, precursor concentrations were
estimated at each time point and then a precursor load was added to reach 2.2 mM (inhibitory precursor
concentration) at time points from 2 to 12 h. This strategy allowed us to improve the D-DIBOA
production from the previously reported 5.01 mM up to 6.80 mM (Figure 5a, left panel), although
around 20% of the precursor added was not biotransformed. It is worth noting that these experiments
also showed that D-DIBOA production is associated with cell growth (Figure 5a, right panel) since the
maximum biotransformation rate was found at log phase (from 2 to 7 h). On the other hand, from
7 to 24 h, cell growth not only remained in stationary phase, but also even decreased and D-DIBOA
production nearly stopped.
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pulse at 7 h to reach 22.2 mM.
Glucose concentration in the culture medium was also associated to the biocatalysis because it was
almost totally consumed at 6 h (Figure 5a, right panel). We reasoned that this could be the cause of cell
growth inhibition. Therefore, in another series of experiments (Figure 5b), glucose loads were applied
to maintain the initial glucose concentration (22.2 mM). However, cell growth did not improve up to
6 h despite the fact that glucose was available for the cells; on the contrary, cell growth and D-DIBOA
production slightly decreased with respect to the previous experiments. Nevertheless, from 12 to 24 h
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cells kept growing at a low rate (Figure 5b, right panel), and consistently, D-DIBOA concentration
increased (Figure 5b, left panel), although the final production was virtually the same as in the assays
with no glucose reloading (6.70 mM). We therefore focused our efforts on improving molar yields
(Figure 5c). In order to do so, the last precursor load was added at the end of the log phase (7 h after the
initial load). We also controlled glucose concentration to improve cell growth by not adding glucose
during the log phase but adding a single load at hour 7 to maintain cell growth for the rest of the
assay (Figure 5c, right panel). This strategy increased D-DIBOA production up to 7.17 mM (Figure 5c,
left panel), transforming 89.90% of the precursor, and therefore increasing the molar yield. In addition,
the bacteria growth slightly increased under these conditions (Figure 5c, right panel).
2.3. Tolerance of the E. coli ∆lapA∆fliQ/pBAD-NfsB Strain to D-DIBOA
As indicated in the previous section, D-DIBOA bioproduction seems to reach a maximum
theoretical concentration at around 7 mM on this strain under the conditions tested in this work.
In order to elucidate whether the cause of this threshold is a toxic effect of D-DIBOA on the bacterial
strain, we studied the tolerance to D-DIBOA on the optimized ∆lapA∆fliQ/pBAD-NfsB and the
parental (BW25113/pBAD-NfsB) strains by analyzing biomass growth on M9 medium containing
increasing D-DIBOA concentrations. The results of this assay show that the optimized strain was
more tolerant to D-DIBOA than the parental one in D-DIBOA concentration range of 1–6 mM.
However, the parental strain was able to grow under concentrations between 7 to 10 mM of D-DIBOA,
while ∆lapA∆fliQ/pBAD-NfsB strain did not grow at 7 mM and even provoked cell lysis at higher
concentrations (Figure 6). We concluded therefore that 7 mM was the limiting toxic D-DIBOA
concentration for this strain.
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Figure 6. Tolerance test on BW251 3/pBAD-NfsB (black bars) and ∆lapA∆fliQ/pBAD-NfsB (grey bars)
Escherichia coli strains for increasing D- IBOA concentrations. Bar charts show relativized values of
bacterial biomass grown for 12 h with respect the biomass at the moment in which D-DIBOA was added,
in an OD600nm = 0.6. Bacterial growth as measured in absence (positive control, C; and positive
control with MeOH, C´) or in the presence of different concentrations of D- IBOA. The error bars
represent the standard deviations of three independent replicates.
3. Discussion
Whole-cell biocatalysts provide unique advantages and have been widely used for the efficient
biosynthesis of value-added fine and bulk chemicals, and pharmaceutically active ingredients [24].
We previously used this approach to produce D-DIBOA, a synthetic analogous to the natural allelopathic
herbicide DIBOA (Figure 1a). This benzohydroxamic acid present in common crops, such as wheat,
rye, and maize, is a promising natural herbicide model, showing high biodegradability in soils,
and therefore, a low environmental impact [2]. However, the main drawbacks for the use of DIBOA and
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other allelopathic compounds in agriculture are their very low natural production and the complexity
of their biosynthetic pathways, which involve multiple enzymes, making them difficult to be translated
to microorganisms for their biotechnological production. The chemical synthesis of the analogous
D-DIBOA is a simpler process that involves only two steps and uses inexpensive starting materials,
although the second step, a difficult and expensive process, is a bottleneck for the industrial production.
This drawback turns, therefore, a green process—the production of an environmentally friendly
herbicide—into an unsustainable and economically unfeasible process. A way to overcome this
problem is biocatalysis, which is based on the specificity and high catalytic capability of enzymes.
Biocatalytic processes also meet the requirements of green chemistry because they are carried out
in aqueous solutions, mild temperatures, and low pressures, and consequently lead to less waste
than chemical syntheses. A biocatalyst can be a cell extract or a purified enzyme used in vitro, either
in solution or immobilized [25]. However, living microorganisms can also be used as whole-cell
biocatalysts, taking advantage of the capacity of a cell to transform an external precursor into the target
chemical compound.
We previously reported that E. coli could be effectively used as a whole-cell biocatalyst to replace
the second reaction of D-DIBOA chemical synthesis by over-expressing the autologous nitroreductase
NfsB [9]. Furthermore, this versatile system also allows the production of D-DIBOA chlorinated
derivatives [26].
Nevertheless, these bacterial biocatalysts can be potentially further improved by genetic
manipulation of the genetic background. For instance, screening of mutant collections has shown to be a
feasible strategy [9]. Other improvements could be based on adaptive evolution approaches in order to
find E. coli strains more tolerant to limiting factors such as high precursor and D-DIBOA concentrations.
On the other hand, the process also needs to be scaled up from an Erlenmeyer flask to higher volume
bioreactors in which the operation mode must be adjusted and automated if possible. Additionally, last
but not least, D-DIBOA must be purified from the culture medium. These downstream procedures are
often some of the most expensive and difficult goals to achieve for the industrial application. All these
processes require multiple experiments that require a reliable but also a fast and inexpensive D-DIBOA
quantification. The current methodology based on HPLC techniques does not meet these requirements.
For instance, the screening of mutants carried out in our laboratory was limited to a relatively low
number of strains, mainly due to the expensive and time-consuming D-DIBOA quantification.
For this reason, before tackling further improvements of the bioprocess, it was compulsory to
establish a faster, easier, and cheaper quantification method. We successfully achieved this goal by
implementing and validating a spectrophotometric method based in the generation of blue colored
Fe(III)-(D-DIBOA)3 complexes (Figure 2). This method allows an accurate quantification in the range
of millimolar concentration in the M9 culture medium used for D-DIBOA bioproduction. An extensive
validation of the method demonstrates that it is as reliable as HPLC in our experimental conditions,
but in contrast to the chromatographic techniques, it can be carried out in a real time manner using
microtiter plates and consuming only 100 µL of sample in the quantification. The equipment and
chemicals required are simple and easy to use, allowing the processing of hundreds of quantification
tests per hour.
As a proof of concept, this method was applied to real biotransformation experiments at laboratory
scale. The monitoring of precursor and D-DIBOA using the methodology proposed in this work at
several time points allowed us to increase D-DIBOA production up to 7.17 mM with 89.9% of molar
yield, and disclosed relevant information about the biocatalysis that could not otherwise be found
(Figure 5). For instance, we found that D-DIBOA production is closely related to cell growth and
the limiting D-DIBOA concentration of 7 mM for the growth in the ∆lapA∆fliQ/pBAD-NfsB strain
(Figure 6).
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4. Materials and Methods
4.1. Bacterial Strains
The E. coli ∆lapA∆fliQ/pBAD-NfsB strain was used as whole-cell-biocatalyst and BW25113/
pBAD-NfsB as wild type strain This strain harbors deletions of the genes encoding for the
lipopolysaccharide assembly protein A (lapA) and the flagellar biosynthesis protein (fliQ); and the
construct pBAD-NfsB [8] that allows the controlled overexpression of the nitroreductase NfsB upon
addition of l-arabinose to the culture medium. This engineered strain was constructed for optimization
of D-DIBOA yield and concentration as described previously [9] and it was registered in the Spanish
Type Culture Collection (CECT 9760).
4.2. Culture Media and Chemicals
The strains used in this work were initially grown in Luria–Bertani (LB) medium and LB agar plates.
For the biotransformation tests, M9 minimal medium was used, containing (g/L): 0.24 MgSO4, 0.01 CaCl2,
11.178 Na2HPO4, 3.00 KH2PO4, 0.50 NaCl, 1.00 NH4Cl, and 4.00 glucose. Chemicals for the culture
media were purchased from Panreac (Barcelona, Spain). The medium was supplemented with 50µg/mL
kanamycin and 100 µg/mL ampicillin when appropriate. NfsB overexpression in the pBAD/His-A
vector was induced by adding 0.02% (w/v) l-arabinose. Antibiotics and l-arabinose were purchased from
Sigma-Aldrich. D-DIBOA and its synthetic precursor—the ethyl-2-(2′-nitrophenoxy)acetate—were
obtained by chemical synthesis kindly provided by Allelopathy Group Organic Chemistry Department,
University of Cadiz [2]. Starting material (2-nitrophenol) and other chemicals such as ethyl bromoacetate
(EtBr), methanol (MeOH), ethanol (EtOH), ferric chloride (FeCl3·6H2O), and hydrogen chloride (HCl),
were purchased from Panreac Quimica (Barcelona, Spain). Biological samples of D-DIBOA were
obtained by biocatalysis in our laboratory.
4.3. Biotransformation Assays
The bacterial strains were streaked from a −80 ◦C glycerol stock on LB agar plates and incubated
overnight at 37 ◦C. A single colony was inoculated in 5 mL LB medium and cultivated at 37 ◦C and
200 rpm in an orbital shaker. After 8 h, the cells were centrifuged at 3000× g for 10 min and the pellet
was resuspended in 100 mL M9 medium containing 0.02% (w/v) l-arabinose, and then it was incubated
overnight in the same conditions; 10 mL of this pre-culture was then centrifuged at 3000× g for 10 min
and resuspended in 100 mL of fresh M9 medium supplemented with 0.02% (w/v) l-arabinose and
grown in a 250 mL Erlenmeyer flask at 37 ◦C. The biotransformation assay was initiated by adding
1 mL of precursor stock solution (50 mg/mL in 100% MeOH) when OD600 arose 0.6; then the precursor
concentration was therefore 0.5 mg/mL (2.22 mM), which was denoted as time point 0 h. In order to
enhance the D-DIBOA titer, successive loads of precursor were done, keeping the concentration at
2.2 mM over the experiment. Another parameter studied was the carbon source; therefore, successive
loads of glucose were also maintained constant at 22.2 mM. For both assays, the rapid quantification
of D-DIBOA method studied in this work was applied. All of the experiments were carried out
in triplicate.
4.4. Chemicals for Benzohydroxamic Acid Determination and Quantification
Stock solutions (200 mM) of D-DIBOA, 2-nitrophenol, and precursor were prepared in 100%
methanol. FeCl3 solutions were prepared by dissolving FeCl3 in ethanol or water and the pH was
adjusted by adding HCl (1.5 M). In the case of D-DIBOA obtained by biotransformation, an appropriated
volume of the bacterial cell culture was centrifuged at 10,000× g for 10 min and the supernatant was
used for quantification.
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4.5. Analytical Instruments and Techniques, Calculation of Parameters, and Statistical Analysis
A UV–visible spectrophotometer (U-2001 spectrophotometer HITACHI Instruments Inc. Tokyo,
Japan) was used to scan the absorbance spectra in the visible range of wavelengths (400–750 nm) in
order to select the maximum wavelength of Fe(III)-(D-DIBOA)3 complex absorption. Multiskan FC®
microtiter reader plate with incubator (Thermo Scientific, Thermo Fisher Scientific, Madrid, Spain)
was used for D-DIBOA quantification in the experiments related to the method validation and in
the whole-cell biocatalysis assays. Precursor and D-DIBOA were additionally measured in some
experiments by reverse-phase high performance liquid chromatography (HPLC) (Merck HITACHI
HPLC system, Tokyo, Japan) equipped with Phenomenex Gemini C18 4.6 × 250 mm column (Torrace,
CA, USA), using the method previously described [8]. Samples were filtered through 0.22 µm nylon
filters (VWR International, Barcelona, Spain) before HPLC analysis.
Cell growth was estimated by measuring OD600 by the ratio, 1 OD600 = 0.33 g of cell dry weight
(CDW)/L, according to standard procedure [27]. Samples were centrifuged at 11,000× g for 5 min in
order to remove biomass before analysis of the rest of the parameters. Glucose concentration was
determined by using the glucose oxidase and peroxidase enzymatic Kit (BioSystems, Barcelona, Spain)
and measured in a microtiter reader plate at 425 nm wavelength.
Biotransformation yield (BY) was calculated from the concentration of D-DIBOA at the




× 100 (%) (1)
Average and standard deviation were calculated using at least 3 replicates.
For the biotransformation assays, precursor concentration in the culture medium (mM) was
stoichiometrically calculated for each time point (t) as follows:
[Precursor]t =




The method for D-DIBOA quantification was validated by taking into consideration the following
parameters: specificity, linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy,
precision, and robustness. Validation of these parameters was applied according to the International
Conference on Harmonization (ICH) guidelines Q2 (R1) [22] and was calculated as follows:
Specificity: It was evaluated by comparing the visible spectra of standard solutions of D-DIBOA
against other compounds that can be present in the biotransformation culture. The analysis scanning
was performed from 450 to 750 nm, checking for changes in absorbance.
Linearity was analyzed by quantifying three different series of five D-DIBOA standard solutions
(0.375, 0.75, 1.5, 3, 4.5 mM), analyzed in triplicate, and plotted in nine derived analytical curves.
The linearity was verified by linear regression analysis using the least squares method (R2).
Limit of detection (LOD) and limit of quantification (LOQ) were determined in order to establish
the sensitivity of the developed method. Both parameters were calculated by LOD = 3.3(S.D/S) and
LOQ = 10(S.D/S) where SD is the standard deviation of the response of the blank and S is the slope of
the analytical curve. Blanks were prepared in M9 medium.
Accuracy was examined by the recovery of a known amount of D-DIBOA added to M9 medium.
For that, three different levels of analyte concentration were used: lower concentration (0.75 mM),
intermediate concentration (1.5 mM), and higher concentration (3.0 mM). Samples were prepared
in triplicate and analyzed using the proposed method. The relative standard deviation (RSD) and
D-DIBOA recovery percentage were used to evaluate the accuracy of the method applied.





Precision was verified by evaluating replicability and intermediate precision (inter-day, intra-day,
and inter-analyst), while analyzing three different levels of D-DIBOA (0.75, 1.5, and 3.0 mM) in triplicate.
Analyses were carried out for two different analysts at two different times during one day for intra-day
precision evaluation. The same procedure was followed in a second day to study inter-day variations.
Firstly, the RSD was calculated; then the values obtained were analyzed by the use of the Horrat









RSDH is the predicted value obtained from the Horwitz equation : 2(1−0.5logC)(%),
where C is the concentration of the analyte.
(6)
5. Conclusions
In this work we have developed a spectrophotometric method for the quantification of the
benzohydroxamic acid D-DIBOA when this compound is dissolved in the defined culture medium.
This method shows high accuracy, precision, and sensitivity. It also shows a high correlation coefficient
(0.9994) with the HPLC quantification method and can be carried out using a low volume of sample on
a microtiter plate reader. This method allowed us to increase 43% D-DIBOA production and will help to
design the operation mode for the scaling up of the D-DIBOA biotechnological production, and will also
facilitate the research on its purification from the culture medium. This approach also could be applied
to the production of others benzohydroxamic acids, such as the chlorinated D-DIBOA derivatives.
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Abbreviations
CV coefficient of variation
DIBOA 2,4-dihydroxy-(2H)-1,4-benzoxazin-3(4H)-one
D-DIBOA 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one
HPLC high performance liquid chromatography
LOD limit of detection
LOQ Limit of quantification
NfsB NAD(P)H-dependent nitroreductase
RSD relative standard deviation
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